Alpha Partners — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Daymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics.
Digital HealthHealthtechMental HealthPhiladelphia, US
Justin Bekelman(Executive Officer, Director)inJonathan Rhodes(Founder)inPaul Dufault(Executive Officer)Roy Beveridge(Director)
BoardKelsey Maguire(Director)Ambar Bhattacharyya(Director)
Co-investorsBlue Venture FundsHealthier CapitalMaverick VenturesOncology VenturesSandbox IndustriesYosemite
Exodigo maps utilities, foundations, and geotechnical conditions beneath infrastructure projects without excavation, using multi-sensor fusion and AI to produce subsurface maps, insights, and visualizations.
AI & Machine LearningConstruction TechDeep Tech
Jeremy Suard(Founder)inOmer HameiriinOriel HalvaniinIliya KatzIdo Gonen(Founder)inIdo Gonen(Founder)
Co-investors10DGreenfield PartnersJibe VenturesNext Legacy PartnersSquare Peg CapitalSuffolk Technologies+5 more
Heva operates an AI-powered medical tourism platform that matches patients with verified healthcare providers abroad, covering fields such as dental, cosmetic surgery, orthopedics, cardiac care, ophthalmology, and bariatric procedures.
AI & Machine LearningDigital HealthHealthtechMarketplacesNew York City, US
Varun Annadi(Executive Officer, Director)inHector Terrero(Director)
Co-investorsSpice CapitalTechstarsThe MBA FundBenchstrength PartnersCollide CapitalFlybridge Capital Partners
Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems.
AI & Machine LearningDigital HealthHealthtechNorth Sydney
Sarah Butler(Director)Merrick Howes(Executive Officer, Director)Rebecca Edwards(Executive Officer)Nicholas Todhunter(Director)Keith Hansen(Executive Officer, Director)Wally Curran(Director)
Co-investorsOncology Ventures
Risa Labs provides automated prior authorization and revenue-cycle workflows for oncology practices, handling Part B and Part D drug authorizations, eligibility and benefit verification, claims status tracking, and denial management.
AI & Machine LearningDigital HealthHealthtech
Kshitij Jaggi(Founder)Kumar Shivang(Founder)
Co-investorsBetter CapitalCencora VenturesOncology VenturesOptum VenturesZ21 VenturesCerity Partners Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





































